Cargando…

Oral health professionals screening for undiagnosed type-2 diabetes and prediabetes: the iDENTify study

BACKGROUND: As part of an evaluation of an oral healthcare practice-based model that identifies patients with prediabetes or type-2 diabetes, this study reports on the proportion of patients identified with clinically confirmed type-2 diabetes (T2D)/prediabetes and barriers of implementation of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mariño, Rodrigo, Priede, Andre, King, Michelle, Adams, Geoffrey G., Sicari, Maria, Morgan, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294826/
https://www.ncbi.nlm.nih.gov/pubmed/35850674
http://dx.doi.org/10.1186/s12902-022-01100-9
_version_ 1784749928905441280
author Mariño, Rodrigo
Priede, Andre
King, Michelle
Adams, Geoffrey G.
Sicari, Maria
Morgan, Mike
author_facet Mariño, Rodrigo
Priede, Andre
King, Michelle
Adams, Geoffrey G.
Sicari, Maria
Morgan, Mike
author_sort Mariño, Rodrigo
collection PubMed
description BACKGROUND: As part of an evaluation of an oral healthcare practice-based model that identifies patients with prediabetes or type-2 diabetes, this study reports on the proportion of patients identified with clinically confirmed type-2 diabetes (T2D)/prediabetes and barriers of implementation of the model. METHODOLOGY: Urban and rural oral healthcare practices were invited to participate. Participating practices invited eligible patients to participate in the screening program using the Australian Type-2 Diabetes Risk Assessment Tool (AUSDRISK). Participants were categorised as low, intermediate, or high-risk for prediabetes/T2D. Patients in the intermediate or high-risk category were referred to their General Medical Practitioner (GP) for further investigation. RESULTS: Fifty-one oral healthcare practices and 76 Oral Health Professionals (OHP) participated (60 Dentists, 8 Dental Hygienists, 8 Oral Health Therapists). 797 patients were screened; 102 were low-risk; 331 intermediate-risk; and 364 high-risk for T2D. Of the 695 participants in the intermediate or high-risk groups, 386 (55.5%) were referred to their GP for T2D assessment. Of them, 96 (25.0%) results were returned to OHPs. Of the returned results, six were (6.3%) diagnosed with pre-T2D. CONCLUSION: Patients found to have undiagnosed T2D/prediabetes (6.3%) were within the expected range reported in the literature. Findings indicate that identifying individuals at an elevated risk of having or developing T2D is effective, feasible and could be incorporated into oral healthcare settings. However, this integration may require additional OHPs training and education to ensure that patients at elevated risk of T2D are referred for further assessment.
format Online
Article
Text
id pubmed-9294826
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92948262022-07-19 Oral health professionals screening for undiagnosed type-2 diabetes and prediabetes: the iDENTify study Mariño, Rodrigo Priede, Andre King, Michelle Adams, Geoffrey G. Sicari, Maria Morgan, Mike BMC Endocr Disord Research BACKGROUND: As part of an evaluation of an oral healthcare practice-based model that identifies patients with prediabetes or type-2 diabetes, this study reports on the proportion of patients identified with clinically confirmed type-2 diabetes (T2D)/prediabetes and barriers of implementation of the model. METHODOLOGY: Urban and rural oral healthcare practices were invited to participate. Participating practices invited eligible patients to participate in the screening program using the Australian Type-2 Diabetes Risk Assessment Tool (AUSDRISK). Participants were categorised as low, intermediate, or high-risk for prediabetes/T2D. Patients in the intermediate or high-risk category were referred to their General Medical Practitioner (GP) for further investigation. RESULTS: Fifty-one oral healthcare practices and 76 Oral Health Professionals (OHP) participated (60 Dentists, 8 Dental Hygienists, 8 Oral Health Therapists). 797 patients were screened; 102 were low-risk; 331 intermediate-risk; and 364 high-risk for T2D. Of the 695 participants in the intermediate or high-risk groups, 386 (55.5%) were referred to their GP for T2D assessment. Of them, 96 (25.0%) results were returned to OHPs. Of the returned results, six were (6.3%) diagnosed with pre-T2D. CONCLUSION: Patients found to have undiagnosed T2D/prediabetes (6.3%) were within the expected range reported in the literature. Findings indicate that identifying individuals at an elevated risk of having or developing T2D is effective, feasible and could be incorporated into oral healthcare settings. However, this integration may require additional OHPs training and education to ensure that patients at elevated risk of T2D are referred for further assessment. BioMed Central 2022-07-18 /pmc/articles/PMC9294826/ /pubmed/35850674 http://dx.doi.org/10.1186/s12902-022-01100-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Mariño, Rodrigo
Priede, Andre
King, Michelle
Adams, Geoffrey G.
Sicari, Maria
Morgan, Mike
Oral health professionals screening for undiagnosed type-2 diabetes and prediabetes: the iDENTify study
title Oral health professionals screening for undiagnosed type-2 diabetes and prediabetes: the iDENTify study
title_full Oral health professionals screening for undiagnosed type-2 diabetes and prediabetes: the iDENTify study
title_fullStr Oral health professionals screening for undiagnosed type-2 diabetes and prediabetes: the iDENTify study
title_full_unstemmed Oral health professionals screening for undiagnosed type-2 diabetes and prediabetes: the iDENTify study
title_short Oral health professionals screening for undiagnosed type-2 diabetes and prediabetes: the iDENTify study
title_sort oral health professionals screening for undiagnosed type-2 diabetes and prediabetes: the identify study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294826/
https://www.ncbi.nlm.nih.gov/pubmed/35850674
http://dx.doi.org/10.1186/s12902-022-01100-9
work_keys_str_mv AT marinorodrigo oralhealthprofessionalsscreeningforundiagnosedtype2diabetesandprediabetestheidentifystudy
AT priedeandre oralhealthprofessionalsscreeningforundiagnosedtype2diabetesandprediabetestheidentifystudy
AT kingmichelle oralhealthprofessionalsscreeningforundiagnosedtype2diabetesandprediabetestheidentifystudy
AT adamsgeoffreyg oralhealthprofessionalsscreeningforundiagnosedtype2diabetesandprediabetestheidentifystudy
AT sicarimaria oralhealthprofessionalsscreeningforundiagnosedtype2diabetesandprediabetestheidentifystudy
AT morganmike oralhealthprofessionalsscreeningforundiagnosedtype2diabetesandprediabetestheidentifystudy